THE POTENTIAL LONG-TERM COMPARATIVE EFFECTIVENESS OF LAROTRECTINIB VS. LENVATINIB OR SORAFENIB FOR TREATMENT OF NTRK FUSION-POSITIVE METASTATIC THYROID CANCER

被引：0
|
作者：
Carlson, J. [1 ]
Suh, K. [2 ]
Xia, F. [3 ]
Williamson, T. [3 ]
Sullivan, S. [4 ]
机构：
[1] Univ Washington, Seattle, WA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Bayer US LLC, Whippany, NJ USA
[4] Univ Washington, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN11
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [41] Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer Long-term Results of Treatment With Trastuzumab and Lapatinib
    Sartore-Bianchi, Andrea
    Lonardi, Sara
    Aglietta, Massimo
    Martino, Cosimo
    Ciardiello, Fortunato
    Marsoni, Silvia
    Siena, Salvatore
    JAMA ONCOLOGY, 2020, 6 (06) : 927 - 929
  • [42] Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study
    Li, Rubi K.
    Tokunaga, Eriko
    Adamchuk, Hryhoriy
    Vladimirov, Vladimir
    Yanez, Eduardo
    Lee, Keun Seok
    Bondarenko, Igor
    Vana, Alicia
    Hilton, Fiona
    Ishikawa, Tomofumi
    Tajima, Kentaro
    Lipatov, Oleg
    BIODRUGS, 2022, 36 (01) : 55 - 69
  • [43] Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study
    Rubi K. Li
    Eriko Tokunaga
    Hryhoriy Adamchuk
    Vladimir Vladimirov
    Eduardo Yanez
    Keun Seok Lee
    Igor Bondarenko
    Alicia Vana
    Fiona Hilton
    Tomofumi Ishikawa
    Kentaro Tajima
    Oleg Lipatov
    BioDrugs, 2022, 36 : 55 - 69
  • [44] Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment with trastuzumab and the potential risk factors.
    Bouwer, N. Nathalie
    Steenbruggen, T. G.
    Rier, H. N.
    Kitzen, J. J. E. M.
    Beelen, K. J.
    Ten Tije, A. J.
    De Jong, P. C.
    Drooger, J. C.
    Holterhues, C.
    Van Rosmalen, J.
    Kofflard, M. J. M.
    Boersma, E.
    Sonke, G. S.
    Levin, M-D
    Jager, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 289 - 290
  • [45] Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only
    de Vries, R. R.
    Nieuwenhuijzen, J. A.
    Meinhardt, W.
    Bais, E. M.
    Horenblas, S.
    EJSO, 2009, 35 (04): : 352 - 355
  • [46] Predictors of long-term durable response in de novo HER2 positive metastatic breast cancer and the real world treatment experience at two institutions
    Smith, Claire E.
    Marcom, Paul K.
    Zahi, Mitri
    Ko, Naomi
    CANCER RESEARCH, 2023, 83 (05)
  • [47] Long-term progression-free-survival (PFS) under sunitinib (SU) treatment for metastatic renal cell carcinoma (Sulong study): Analysis of two populations - long term responders (LR) vs. primary refractory (PR) patients
    Puente, J.
    Lainez, N.
    Castellano, D. E.
    Basterretxea, L.
    Leon, L.
    Perez-Valderrama, B.
    Lambea, J.
    Vazquez, S.
    Anton-Aparicio, L.
    Esteban, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S665 - S666
  • [48] Oculomotor nerve palsy recovery following microsurgery vs. endovascular treatment of posterior communicating artery aneurysms: a comparative meta-analysis of short- and long-term outcomes
    Abo Kasem, Rahim
    Cunningham, Conor
    Elawady, Sameh Samir
    Sowlat, Mohammad Mahdi
    Babool, Sofia
    Hulou, Saad
    Hubbard, Zachary
    Orscelik, Atakan
    Musmar, Basel
    Spiotta, Alejandro M.
    NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [49] Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer
    O'Sullivan, Joe M.
    McKay, Rana R.
    Rahbar, Kambiz
    Fizazi, Karim
    George, Daniel J.
    Tombal, Bertrand
    Schmall, Anja
    Sandstrom, Per
    Verholen, Frank
    Shore, Neal
    FRONTIERS IN MEDICINE, 2022, 9
  • [50] Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer - results from the HER-OS patient registry
    Witzel, Isabell
    Mueller, Volkmar
    Abenhardt, Wolfgang
    Kaufmann, Manfred
    Schoenegg, Winfried
    Schneeweis, Andreas
    Jaenicke, Fritz
    BMC CANCER, 2014, 14
12345